Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Medulloblastoma × Thalidomide × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 48 Neoplasms, Plasma Cell 19 Central Nervous System Neoplasms 10 Prostatic Neoplasms 9 Glioblastoma 9 Recurrence 8 Brain Neoplasms 8 Neoplasms 7 Melanoma 7 Gliosarcoma 7 Carcinoma, Non-Small-Cell Lung 6 Waldenstrom Macroglobulinemia 5 Sarcoma 5 Leukemia 5 Glioma 5 Colorectal Neoplasms 5 Myeloproliferative Disorders 4 Lymphoma 4 Lung Neoplasms 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Kidney Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Myelodysplastic-Myeloproliferative Diseases 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Immunoglobulin Light-chain Amyloidosis 3 Colonic Neoplasms 3 Astrocytoma 3

Interventions

Cyclophosphamide 16 Etoposide 11 Temozolomide 10 Magnetic Resonance Spectroscopy 8 Filgrastim 8 Cisplatin 8 Vincristine 7 Radiotherapy 7 Irinotecan 7 Carboplatin 7 X-Rays 6 Phantoms, Imaging 6 Topotecan 5 Specimen Handling 5 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Thiotepa 4 Biopsy 4 Bevacizumab 4 sargramostim 3 palbociclib 3 olaparib 3 Methotrexate 3 Chemotherapy, Adjuvant 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 sonidegib 2 selpercatinib 2 larotrectinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡